Susquehanna International Group, LLP Cellectar Biosciences, Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.6 - $7.8 $231,177 - $391,996	-50,256 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.1 - $10.2 $306,561 - $512,611	50,256 New	50,256 $33,000
Q2 2020 Aug 14, 2020	SELL	$10.3 - $17.3 $575,450 - $966,533	-55,869 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.0 - $31.7 $614,559 - $1.77 Million	55,869 New	55,869 $71,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $1.47M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.